Observational studyFrontiers in immunology2025

Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort.

Xiamei Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.